Published in Dig Dis Sci on January 01, 1992
Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol (2000) 4.49
Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol (2002) 3.71
Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol (1999) 2.97
Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol (1999) 2.70
Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl Environ Microbiol (1993) 2.03
The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol (1997) 2.03
Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut (1998) 1.96
Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol (1997) 1.84
Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut (2002) 1.74
Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child (1993) 1.56
Are probiotics detectable in human feces after oral uptake by healthy volunteers? Wien Klin Wochenschr (2007) 1.51
Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci (2002) 1.38
Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice. Appl Environ Microbiol (2002) 1.22
Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clin Microbiol Rev (2014) 1.17
Bacterial cinnamoyl esterase activity screening for the production of a novel functional food product. Appl Environ Microbiol (2007) 1.14
Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content. Lipids Health Dis (2009) 1.12
Survival of probiotic lactobacilli in acidic environments is enhanced in the presence of metabolizable sugars. Appl Environ Microbiol (2005) 1.09
Development and validation of a nested-PCR-denaturing gradient gel electrophoresis method for taxonomic characterization of bifidobacterial communities. Appl Environ Microbiol (2003) 1.05
Permanent colonization by Lactobacillus casei is hindered by the low rate of cell division in mouse gut. Appl Environ Microbiol (2004) 1.03
Preliminary evaluation of Lactobacillus rhamnosus strain GG, a potential probiotic in dogs. Can Vet J (2002) 0.99
Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med (2011) 0.97
Functional analysis of the fructooligosaccharide utilization operon in Lactobacillus paracasei 1195. Appl Environ Microbiol (2007) 0.95
Towards a better understanding of Lactobacillus rhamnosus GG--host interactions. Microb Cell Fact (2014) 0.93
Preliminary investigation of the probiotic potential of Lactobacillus rhamnosus strain GG in horses: fecal recovery following oral administration and safety. Can Vet J (2003) 0.92
Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread. Appl Environ Microbiol (2009) 0.92
Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria. Appl Environ Microbiol (1999) 0.92
Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science. Antiinflamm Antiallergy Agents Med Chem (2009) 0.89
Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk. Appl Environ Microbiol (2006) 0.87
Do probiotics prevent childhood illnesses? BMJ (2001) 0.86
Submerged fermentation of Lactobacillus rhamnosus YS9 for γ-aminobutyric acid (GABA) production. Braz J Microbiol (2013) 0.85
Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages. Gut Microbes (2012) 0.84
Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study. J Korean Med Sci (2010) 0.83
Growth phase-associated changes in the proteome and transcriptome of Lactobacillus rhamnosus GG in industrial-type whey medium. Microb Biotechnol (2011) 0.82
Management of acute diarrhoea with low osmolarity oral rehydration solutions and Lactobacillus strain GG. Arch Dis Child (1998) 0.82
Dietary therapy with Lactobacillus GG, bovine colostrum or bovine immune colostrum in patients with juvenile chronic arthritis: evaluation of effect on gut defence mechanisms. Inflammopharmacology (1997) 0.82
Genomic characterization of non-mucus-adherent derivatives of Lactobacillus rhamnosus GG reveals genes affecting pilus biogenesis. Appl Environ Microbiol (2014) 0.81
Anti-diabetic effects of lactic acid bacteria in normal and type 2 diabetic mice. J Clin Biochem Nutr (2012) 0.81
Difference in Degradation Patterns on Inulin-type Fructans among Strains of Lactobacillus delbrueckii and Lactobacillus paracasei. Biosci Microbiota Food Health (2013) 0.80
Effect of Lactobacillus-fermented diets on bacterial translocation and intestinal flora in experimental prehepatic portal hypertension. Dig Dis Sci (2003) 0.79
Detection and characterization of Bifidobacterium crudilactis and B. mongoliense able to grow during the manufacturing process of French raw milk cheeses. BMC Microbiol (2013) 0.78
Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities. Antimicrob Agents Chemother (2015) 0.78
Lactobacillus plantarum WCFS1 and its host interaction: a dozen years after the genome. Microb Biotechnol (2016) 0.77
Phylogenetic identification of bacterial MazF toxin protein motifs among probiotic strains and foodborne pathogens and potential implications of engineered probiotic intervention in food. Cell Biosci (2012) 0.77
A non-dairy probiotic's (poi) influence on changing the gastrointestinal tract's microflora environment. Altern Ther Health Med (2005) 0.76
Comparison of the Growth of Lactobacillus delbrueckii, L. paracasei and L. plantarum on Inulin in Co-culture Systems. Biosci Microbiota Food Health (2014) 0.76
Bacteriological evaluation of dog and cat diets that claim to contain probiotics. Can Vet J (2003) 0.76
Preserving viability of Lactobacillus rhamnosus GG in vitro and in vivo by a new encapsulation system. J Control Release (2016) 0.75
Effect of butyrate and Lactobacillus GG on a butyrate receptor and transporter during Campylobacter jejuni exposure. FEMS Microbiol Lett (2017) 0.75
Lactobacillus rhamnosus strain GG is a potential probiotic for calves. Can J Vet Res (2004) 0.75
Treatment of Recurrent Clostridium difficile Diarrhea. Gastroenterol Hepatol (N Y) (2006) 0.75
Effect of short-term probiotic Enterococcus faecium SF68 dietary supplementation in overweight and obese cats without comorbidities. Vet Rec Open (2016) 0.75
Diversity of key players in the microbial ecosystems of the human body. Sci Rep (2015) 0.75
In vitro and in vivo survival and colonic adhesion of Pediococcus acidilactici MTCC5101 in human gut. Biomed Res Int (2013) 0.75
Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer. Front Pharmacol (2017) 0.75
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med (1978) 14.65
Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans. Infect Immun (1975) 14.65
Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 9.99
Susceptibility of anaerobes to cefoxitin and other cephalosporins. Antimicrob Agents Chemother (1975) 8.86
In vitro activity of thienamycin. Antimicrob Agents Chemother (1978) 8.76
Anaerobic infections. 1. N Engl J Med (1974) 8.02
Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease. J Infect Dis (1971) 7.10
In vitro activity of LY127935. Antimicrob Agents Chemother (1979) 7.01
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet (2001) 6.82
Acute undifferentiated human diarrhea in the tropics. I. Alterations in intestinal micrflora. J Clin Invest (1971) 6.23
Toxigenic Escherichia coli: a cause of infantile diarrhea in Chicago. N Engl J Med (1972) 5.45
Treating diarrhoea. BMJ (1997) 5.22
Travelers' diarrhea and toxigenic Escherichia coli. N Engl J Med (1975) 5.20
Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli. Infect Immun (1974) 4.79
Identification of enterotoxigenic Escherichia coli and serum antitoxin activity by the vascular permeability factor assay. Infect Immun (1973) 4.07
Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun (1978) 3.93
Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun (1974) 3.91
In vitro activity of N-formimidoyl thienamycin (MK0787). Antimicrob Agents Chemother (1980) 3.90
Intestinal microflora. Gastroenterology (1971) 3.86
Intestinal flora in health and disease. Gastroenterology (1984) 3.84
Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83
Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and fecal flora. Gastroenterology (1967) 3.71
Management of anaerobic infections. Ann Intern Med (1975) 3.62
Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol (2001) 3.61
Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology (1967) 3.60
Rapid diagnosis of anaerobic infections by direct gas-liquid chromatography of clinical speciments. J Clin Invest (1976) 3.34
Microbial synergy in experimental intra-abdominal abscess. Infect Immun (1976) 3.21
Abdominal trauma, anaerobes, and antibiotics. Surg Gynecol Obstet (1973) 3.18
Anaerobic infections (second of three parts). N Engl J Med (1974) 3.18
Anaerobic infections (third of three parts). N Engl J Med (1974) 3.13
Intestinal fluid and electrolyte transport in human cholera. J Clin Invest (1970) 3.09
Studies on enterotoxin from Escherichia coli associated with acute diarrhea in man. J Lab Clin Med (1971) 3.03
Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ (2001) 2.91
Inactivation of cephalosporins by Bacteroides. Antimicrob Agents Chemother (1979) 2.75
Pseudomembranous enterocolitis (antibiotic-related colitis). Adv Intern Med (1977) 2.73
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother (1984) 2.71
Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol (1999) 2.70
Hormone levels during dietary changes in premenopausal African-American women. J Natl Cancer Inst (1996) 2.59
Effect of preoperative neomycin-erythromycin intestinal preparation on the incidence of infectious complications following colon surgery. Ann Surg (1973) 2.57
Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis (1975) 2.56
Species and type phages of lactococcal bacteriophages. Intervirology (1991) 2.55
Stimulation of intestinal adenyl cyclase by Escherichia coli enterotoxin: comparison of strains from an infant and an adult with diarrhea. J Infect Dis (1974) 2.52
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother (1985) 2.47
Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics (1999) 2.45
Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins. Infect Immun (1978) 2.39
Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis. J Infect Dis (1979) 2.38
Preoperative oral antibiotics reduce septic complications of colon operations: results of prospective, randomized, double-blind clinical study. Ann Surg (1977) 2.36
Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals. Infect Immun (1974) 2.33
Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr (1995) 2.30
Rapid microbiological assay for chloramphenicol and tetracyclines. Antimicrob Agents Chemother (1976) 2.26
Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother (1987) 2.25
Acute undifferentiated human diarrhea in the tropics. II. Alterations in intestinal fluid and electrolyte movements. J Clin Invest (1971) 2.22
Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci (1987) 2.17
Probiotics: effects on immunity. Am J Clin Nutr (2001) 2.10
Anaerobic infections of the female genital tract: bacteriologic and therapeutic aspects. Am J Obstet Gynecol (1973) 2.07
The human intestinal microflora. Dig Dis Sci (1986) 2.07
Demonstration of safety of probiotics -- a review. Int J Food Microbiol (1998) 2.02
Probiotics in the management of atopic eczema. Clin Exp Allergy (2000) 2.00
Bacteriology of empyema. Lancet (1974) 2.00
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother (2007) 1.95
Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res (2002) 1.92
Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med (1990) 1.90
Efficacy of preoperative antimicrobial preparation of the bowel. Ann Surg (1972) 1.88
Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet (1987) 1.88
Purification of Shigella dysenteriae 1 (Shiga)-like toxin from Escherichia coli O157:H7 strain associated with haemorrhagic colitis. Lancet (1983) 1.87
Anaerobes survive in clinical specimens despite delayed processing. J Clin Microbiol (1976) 1.87
Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst (1994) 1.85
Antimicrobial use in animal feed--time to stop. N Engl J Med (2001) 1.84
Attachment pili from enterotoxigenic Escherichia coli pathogenic for humans. Infect Immun (1979) 1.80
Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy. Gastroenterology (1968) 1.80
Anaerobic microflora of the cervix in healthy women. Am J Obstet Gynecol (1973) 1.78
Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med (1982) 1.77
Studies of intestinal microflora. IV. The microflora of ileostomy effluent: a unique microbial ecology. Gastroenterology (1967) 1.76
Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis (2000) 1.74
Bacteria, bile, and the small bowel. Gut (1969) 1.74
Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med (1976) 1.73
Soybean phytoestrogen intake and cancer risk. J Nutr (1995) 1.72
Serotypes of attachment pili of enterotoxigenic Escherichia coli isolated from humans. Infect Immun (1981) 1.72
Superoxide dismutase in anaerobic bacteria of clinical significance. Infect Immun (1977) 1.68
Autoantibodies typical of non-organ-specific autoimmune diseases in HIV-seropositive patients. AIDS (1992) 1.65
Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett Appl Microbiol (1997) 1.65
Candida infections in surgical patients. Ann Surg (1983) 1.63
Acute diarrhea--a "toxin" disease? N Engl J Med (1970) 1.63
Effect of dissolved oxygen and Eh and Bacteroides fragilis during continuous culture. Appl Environ Microbiol (1976) 1.62
The microflora of the human ileum and intrabdominal colon: results of direct needle aspiration at surgery and evaluation of the technique. J Lab Clin Med (1972) 1.61
Hemagglutination and adhesiveness of toxigenic Escherichia coli isolated from humans. Infect Immun (1979) 1.60
Rapid identification of Clostridium difficile by toxin detection. J Clin Microbiol (1982) 1.59
Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr (1991) 1.57
Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med (1990) 1.54
Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab (1996) 1.53
Ability of dairy strains of lactic acid bacteria to bind a common food carcinogen, aflatoxin B1. Food Chem Toxicol (1998) 1.52
Is it normal for terminally ill patients to desire death? Am J Psychiatry (1986) 1.50
Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy (2007) 1.49
The triple threat of aspiration pneumonia. Chest (1975) 1.48
Alterations in human intestinal microflora during experimental diarrhoea. Gut (1970) 1.48
Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob Agents Chemother (1987) 1.47
Polyunsaturated fatty acids in maternal diet, breast milk, and serum lipid fatty acids of infants in relation to atopy. Allergy (2001) 1.47
Antibiotics and Clostridium difficile. N Engl J Med (1999) 1.47